지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2007.1
- 수록면
- 37 - 39 (3page)
이용수
초록· 키워드
오류제보하기
A patient with adenocarcinoma of the lung was treated sequentially using two kinds of EGFR tyrosine kinase inhibitors, gefitinib and erlotinib. The patient was a 73-year-old female who received gefitinib as a second line treatment, which resulted in a partial response with response duration of 6 months. After progression of the disease, the patient received erlotinib, which resulted in partial response again with response duration of 11.5 months. This observation suggests that treatment with erlotinib may be effective in patients who develop progressive disease after a primary treatment with gefitinib following an initial response. (Cancer Res Treat. 2007;39:37-39)
목차
등록된 정보가 없습니다.
참고문헌 (7)
참고문헌 신청
Choong NW / 2006 / Gefitinib response of erlotinib- refractory lung cancer involving meninges-role of EGFR mutation 3 : 50 ~ 57
Garfield DH / 2005 / Response to Erlotinib after failure of Gefitinib in a patient with advanced non-small-cell lung carcinoma 23 : 7738 ~ 7740
Han SW / 2005 / Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib 23 : 2493 ~ 2501
Lee DH / 2005 / Gefitinib as a first-line therapy of advanced or metastatic adenocarcinoma of the lung in never-smokers 11 : 3032 ~ 3037
Shepherd FA / 2005 / Erlotinib in previously treated non- small-cell lung cancer 353 : 123 ~ 132
Garfield DH / 2005 / Response to Erlotinib after failure of Gefitinib in a patient with advanced non-small-cell lung carcinoma 23 : 7738 ~ 7740
Han SW / 2005 / Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib 23 : 2493 ~ 2501
Lee DH / 2005 / Gefitinib as a first-line therapy of advanced or metastatic adenocarcinoma of the lung in never-smokers 11 : 3032 ~ 3037
Shepherd FA / 2005 / Erlotinib in previously treated non- small-cell lung cancer 353 : 123 ~ 132
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Erlotinib에 대한 내성 발생 후 Gefitinib에 반응한 진행성 폐선암 1예
Tuberculosis and Respiratory Diseases
2011 .01
-
여성 폐암 환자에서 Gefitinib과 Erlotinib 치료 성적 비교
대한내과학회지
2009 .01
-
진행성 비소세포폐암 환자에서 Gefitinib와 Erlotinib의 비교
Tuberculosis and Respiratory Diseases
2009 .01
-
Bowel Perforation after Erlotinib Treatment in a Patient with Non-Small Cell Lung Cancer
Yonsei Medical Journal
2011 .01
-
Recurrent Erlotinib-Induced Interstitial Lung Disease on Non-Small Cell Lung Cancer
Tuberculosis and Respiratory Diseases
2009 .01
-
Comparison of Therapeutic Efficacy of Gefitinib and Erlotinib in Patients with Squamous Cell Lung Cancer
Tuberculosis and Respiratory Diseases
2011 .01
-
Clinical Outcomes and Prognostic Factors Associated with the Response to Erlotinib in Non-Small-Cell Lung Cancer Patients with Unknown EGFR Mutational Status
Asian Pacific journal of cancer prevention : APJCP
2013 .01
-
Erlotinib과 Warfarin의 동시 투여로 PT-INR이 연장된 1예
대한내과학회지
2011 .01
-
Erlotinib-Related Spontaneous Pneumothorax in Patient with Primary Lung Cancer
Tuberculosis and Respiratory Diseases
2010 .01
-
A Case of Cicatricial Alopecia Associated with Erlotinib
Annals of Dermatology
2011 .01
-
Pemetrexed-Erlotinib, Pemetrexed Alone, or Erlotinib Alone as Second-Line Treatment for East Asian and Non-East Asian Never-Smokers with Locally Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer: Exploratory Subgroup Analysis of a Phase II Trial
Cancer Research and Treatment
2015 .01
-
Successful Treatment with Empirical Erlotinib in a Patient with Respiratory Failure Caused by Extensive Lung Adenocarcinoma
Acute and Critical Care
2016 .01
-
Black Hairy Tongue Associated with Erlotinib Treatment in a Patient with Advanced Lung Cancer
Annals of Dermatology
2011 .01
-
Retraction: Prognostic and Predictive Value of Carcinoembryonic Antigen and Cytokeratin-19 Fragments Levels in Advanced Non-Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib. Yonsei Med J 2012;53:931-9.
Yonsei Medical Journal
2013 .01
-
Phase II Trial of Erlotinib Plus Gemcitabine Chemotherapy in Korean Patients with Advanced Pancreatic Cancer and Prognostic Factors for Chemotherapeutic Response
Gut and Liver
2013 .01
-
비편평세포, 비소세포폐암 환자에서 erlotinib, gefitinib 및 pemetrexed의 효과
대한내과학회지
2010 .01
-
Histone Deacetylase Inhibitor Trichostatin A Enhances Antitumor Effects of Docetaxel or Erlotinib in A549 Cell Line
Asian Pacific journal of cancer prevention : APJCP
2012 .01
-
A Phase II Study of Poziotinib in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Lung Adenocarcinoma Who Have Acquired Resistance to EGFR–Tyrosine Kinase Inhibitors
Cancer Research and Treatment
2017 .01
-
EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
Cancer Research and Treatment
2019 .01
-
Incorporating Erlotinib or Irinotecan Plus Cisplatin into Chemoradiotherapy for Stage III Non-small Cell Lung Cancer According to EGFR Mutation Status
Cancer Research and Treatment
2017 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0